Brazil’s laboratory Oswaldo Cruz Foundation (Fiocruz) postponed to March the delivery of the first doses of the Oxford/AstraZeneca COVID-19 vaccine to be produced in the country. Even if it receives the supplies expected to arrive on the 23rd, the institution will need tests and quality control that will require more time, reported O Estado de São Paulo.
The one-month delay should further complicate the implementation of the national immunization plan. For now, states are vaccinating the population with the only one that Brazil can rely on: Coronavac, Sao Paulo’s Butantan Institute vaccine in partnership with China’s Sinovac.
According to the blog of Brazilian journalist Júlia Dualibi, Butantan expects to receive next week a shipment of inputs that was held in China. The batch consists of 5,400 liters of the active ingredient, enough to make another 5.5 million doses of Coronavac.
Meanwhile, North of Brazil is still getting a tough time suffering from a lack of oxygen in hospitals amid the pandemic. After Manaus (Amazonas’ capital), there are oxygen shortages in other cities in Amazonas and Pará. At least 24 deaths have been recorded in these locations, which have difficulties transferring patients, reported O Estado de São Paulo.